CIM
Chiron Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,891
| Closed | -$234K | – | 103 |
|
|
2023
Q2 | $234K | Buy |
1,891
+1,661
| +722% | +$206K | 0.07% | 99 |
|
|
2023
Q1 | $33.7K | Sell |
230
-1,790
| -89% | -$262K | 0.01% | 126 |
|
|
2022
Q4 | $322K | Buy |
+2,020
| New | +$322K | 0.08% | 69 |
|
|
2021
Q3 | – | Sell |
-136,817
| Closed | -$24.3M | – | 114 |
|
|
2021
Q2 | $24.3M | Buy |
+136,817
| New | +$24.3M | 2.93% | 11 |
|
|
2020
Q4 | $14.5M | Buy |
87,783
+2,430
| +3% | +$401K | 2.01% | 17 |
|
|
2020
Q3 | $12.2M | Buy |
+85,353
| New | +$12.2M | 2.26% | 14 |
|
|
2020
Q2 | – | Sell |
-2,400
| Closed | -$239K | – | 82 |
|
|
2020
Q1 | $239K | Buy |
+2,400
| New | +$239K | 0.06% | 42 |
|
|
2019
Q1 | – | Sell |
-1,219
| Closed | -$151K | – | 61 |
|
|
2018
Q4 | $151K | Buy |
1,219
+200
| +20% | +$24.8K | 0.02% | 45 |
|
|
2018
Q3 | $171K | Sell |
1,019
-653
| -39% | -$110K | 0.01% | 55 |
|
|
2018
Q2 | $288K | Buy |
+1,672
| New | +$288K | 0.02% | 42 |
|